INS and type 2 diabetes mellitus: This study aims to evaluate the long-term cost-effectiveness of Degludec insulin liraglutide injection in adult type 2 diabetes mellitus patients with poor glycemic control, to inform health care and health policymakers, as well as provide evidence for hospital drug selection and rational clinical use.